Transfusion Related Complication Clinical Trial
Official title:
Effects of Packed Red Blood Cell Storage Duration on Pediatric Living Donor Liver
Verified date | May 2020 |
Source | RenJi Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The patients assigned to either short-storage leukoreduced RBCs group (stored for ≤ 14 days) or longer-term storage leukoreduced RBCs group(stored for ≥21 days).When the hemoglobin concentration fell below 7.0 g per deciliter, PRBC were given to maintain the hemoglobin concentrations in the range of 7.0 to 10.0/dL. The primary outcome : Death from all causes in1-year after randomization. Secondary outcomes included: Intraoperative blood transfusion, Postoperative blood transfusion, Postoperative inflammatory reaction, Mechanical ventilation time in the intensive care unit, Lengths of stay in the intensive care unit and the hospital were also recorded.
Status | Not yet recruiting |
Enrollment | 360 |
Est. completion date | August 1, 2024 |
Est. primary completion date | July 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 36 Months |
Eligibility |
Inclusion Criteria: - Our study included pediatric patients (6 months< the moon's age <36 months) who will receive standard living-donor liver transplantation (LDLT) in Renji Hospital. Exclusion Criteria: - The exclu¬sion criteria of the study were a congenital sufferer from heart, lung, kidney, nervous system or blood disease,active Lung infection,a history of liver transplantation,Multivisceral transplantation , refused to participate the study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
RenJi Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mortality in in1-year after randomization | Death from all causes in1-year after randomization. | 1-year after randomization. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05699005 -
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
|
Phase 1 | |
Recruiting |
NCT06403163 -
Transfusion Surveillance in Anaesthesia
|
||
Not yet recruiting |
NCT02587845 -
Use of Transexamic Acid in Hip Replacement
|
Phase 3 | |
Completed |
NCT03365999 -
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
|
Phase 2 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Not yet recruiting |
NCT02139995 -
West-China Transfusion Score for Critically-ill Patients
|
Phase 3 | |
Completed |
NCT04513249 -
Effects of Therapeutic Plasmaexhange on Viscoelastic Tests in Non-coagulopathic Patients
|
||
Not yet recruiting |
NCT03934112 -
Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
|
||
Completed |
NCT03394274 -
Restrictive Versus Liberal Transfusion, Major Surgeries
|
N/A | |
Not yet recruiting |
NCT06399536 -
Individualized ANH for Non-cardiac Surgery
|
N/A | |
Withdrawn |
NCT04388722 -
Monitoring Noninvasively for Infusion and Transfusion Optimization
|
N/A | |
Completed |
NCT03476005 -
Proficiency Based Training to Investigate WBIT
|
N/A | |
Recruiting |
NCT03999229 -
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
|
Phase 1 | |
Recruiting |
NCT02461264 -
Transfusion Strategy in Hematological Intensive Care Unit
|
Phase 3 | |
Terminated |
NCT01915654 -
Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients
|
N/A | |
Not yet recruiting |
NCT05696210 -
Evaluation of the 1-year Prognosis of Patients Under Veno-arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock With Blood Transfusion Requirement
|
||
Completed |
NCT04286984 -
Implementation of a Patient Blood Management Program in Gastric Cancer Surgery
|
||
Completed |
NCT03764813 -
Cord Blood Transfusion In Preterm Neonates (CB-TrIP)
|
||
Withdrawn |
NCT04383756 -
Utilization of Donor Whole Blood for Blood Transfusion in Deceased Donor Liver Transplantation
|
Early Phase 1 | |
Completed |
NCT03815773 -
PRospective Multicenter Observational Study on Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
|